EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery

Austin Royster, Songyang Ren, Yutian Ma, Melissa Pintado, Eunice Kahng, Sean Rowan, Sheema Mir iD, Mohammad Mir iD

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.01186-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Austin Royster und 7 weiteren Autor:innen. Beteiligte Einrichtung: Western University of Health Sciences, Pomona, California, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Western University of Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The lack of potent antiviral drugs for SARS-CoV-2 is a serious global health concern, especially with the explosive spread of the COVID-19 pandemic worldwide and the constant emergence of new mutant strains with improved human-to-human transmission. Although an effective coronavirus vaccine appears promising, the lengthy vaccine development processes in general and the emergence of new mutant viral strains with a potential to evade the vaccine always remain a serious concern.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2COVID-19 VaccinesPandemicsCaco-2 CellsDrug DiscoveryAntiviral AgentsNucleocapsid Proteins

Stichwörter der Autor:innen

RNA virusantiviral agentscoronavirusnucleocapsid proteinvirus replication

Substanzen

COVID-19 VaccinesAntiviral AgentsNucleocapsid Proteins

Autor:innen und Institutionen

  • Western University of Health Sciences, Pomona, California, USA.

ORCID-Profile: Sheema Mir, Mohammad Mir

Förderung

  • Western University of Health Sciences

Zitieren

APA

Royster, A., Ren, S., Ma, Y., Pintado, M., Kahng, E., Rowan, S., Mir, S., & Mir, M. (2023). SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01186-23

Vancouver

Royster A, Ren S, Ma Y, Pintado M, Kahng E, Rowan S, et al. SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery. Microbiology Spectrum. 2023. doi:10.1128/spectrum.01186-23

BibTeX
@article{Royster2023,
  author = {Royster, Austin and Ren, Songyang and Ma, Yutian and Pintado, Melissa and Kahng, Eunice and Rowan, Sean and Mir, Sheema and Mir, Mohammad},
  title = {SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.01186-23}
}
Kostenlos starten →